Obesity is considered ordinarily to be a consequence of overeating by an otherwise normal person, but the notion persists that there may be some underlying metabolic defect. Metabolism of obese subjects has been examined by measuring metabolic events in the forearm, which is predominantly skeletal muscle and adipose tissue, in the search for answers to the following questions. 1) What departures from normal take place in basal forearm metabolism of obese subjects and what light do these differences shed on adaptation to chronic substrate excess? 2) Is "simple" obesity related to maturity onset diabetes mellitus, in which obesity is common? Because resistance to exogenous insulin occurs in untreated maturity onset diabetes (4), response to intra-arterial -insulin was examined in simple obesity. From the observations it became clear that there are a number of similarities in metabo-
Metabolism of obese subjects has been examined by measuring metabolic events in the forearm, which is predominantly skeletal muscle and adipose tissue, in the search for answers to the following questions. 1) What departures from normal take place in basal forearm metabolism of obese subjects and what light do these differences shed on adaptation to chronic substrate excess? 2) Is "simple" obesity related to maturity onset diabetes mellitus, in which obesity is common? Because resistance to exogenous insulin occurs in untreated maturity onset diabetes (4) Six young subjects were studied, four men and two women, all approximately 20 per cent overweight but otherwise healthy. All had been actively gaining weight in the 6 to 12 months preceding the test, and in none was there a family history of diabetes. Results of oral glucose tolerance tests with 100 g glucose, performed in five of the six subjects, were normal. Subjects were given a 200-g carbohydrate diet for the 3 days before the test. No food was permitted after 8:00 p.m. the previous night. The test was performed between 9 :00 a.m. and 1:00 p.m., that is, 13 to 17 hours after the last meal.
A brachial artery, an ipsilateral antecubital vein draining mostly muscle, and a superficial vein draining mostly forearm adipose tissue and skin were cannulated by techniques described previously (5) . Blood flow was measured by the indicator-dilution method, based on continuous injection of T-1824 (Evans' blue) dye at constant rate. Circulation to the wrist and hand was excluded during experimental periods by a sphygmomanometer cuff inflated to at least 100 mm Hg beyond systolic pressure.
Uptake or production of a metabolite by the forearm is given by the equation Q = F(A -DV), where F is blood or plasma flow in milliliters per minute per 100 ml of forearm, A is concentration of metabolite in arterial blood or plasma, and DV is its concentration in deep venous blood. This Q will be referred to as "forearm muscle metabolic rate" even though it underestimates true muscle metabolism. To obtain Q per 100 g muscle, it is necessary to know the fraction of total flow that perfuses muscle and the fraction of total forearm that is muscle mass. With representative figures of 0.82 and 0.6, respectively, for these fractions in normal subjects (5), Q per 100 g of muscle is obtained by multiplying the experimental value of Q (shown later in Tables I and II) by a factor, f, of 1.37. The greater proportion of adipose tissue in the forearm of subjects who are 20 per cent overweight may reduce the fraction of total forearm volume occupied by muscle to about 0.5. The fraction of total flow that perfuses muscle in the obese forearm is probably less than 0.82, but probably not as low as 0.67, (6) that obese subjects show resistance to the hypoglycemic effects of intravenously administered insulin, we have examined the response of the forearm of these six obese subjects to a dose of intra-arterial insulin, standardized previously in normal subjects (7) . Glucagon-free insulin 1 Arterial concentrations. There were no significant differences in the mean arterial concentrations of the metabolites studied in the obese group compared to the control values. The mean arterial concentration of FFA was 0.79 mEq per L in the obese subjects; while there have been reports of increased venous FFA levels in obese subjects (9), we have not, in a small series, demonstrated consistent arterial hyperlipacidemia.
Blood flow. Total forearm blood flow in obese subjects did not differ from control subjects. We are unable to estimate what the fractional flow is through muscle and through subcutaneous adipose tissue and skin.
Potassium uptake. Net movement of potassium out of resting muscle into plasma, characteristic in control subjects under the conditions of these experiments (8, 10) , was absent in the obese subjects, who had no net movement of potassium.
Glucose uptake. Mean glucose A-DV concentration difference and mean glucose uptake by forearm muscle were both significantly greater than those of controls.
Lactate production. Mean lactate A-DV concentration difference and mean lactate production by forearm muscle in obese subjects did not differ significantly from those of control subjects. 02 uptake, CO2 production, and respiratory quotient (RQ). No differences from controls were apparent in 02 consumption or CO2 productinon by forearm muscle in obese subjects. The RQ of 0.7, as in normal muscle, is compatible with lipid oxidation.
A-DV FFA difference. Mean FFA A-DV concentration difference in obese subjects was + 0.02 IAEq per ml, which does not differ from the mean value in control subjects (8) . Direct demonstration that this fraction of plasma lipid serves as a major substrate for forearm muscle in obese subjects has not been possible. The anatomical factors believed to underly this have been discussed in detail elsewhere (8) . In brief, it is probable that release into deep venous blood of FFA from adipose tissue surrounding muscle masks the positive A-V FFA concentration difference across forearm muscle proper. Since there is undoubtedly a greater mass of adipose tissue in the obese forearm, it is of some interest that A-DV FFA differences were not more negative in the obese subject than in controls.
The probable metabolic fate of glucose. The L/G ratio-which, as explained in a footnote to Table II , defines the fraction of glucose uptake accounted for by lactate production-was significantly lower in forearm muscle of obese subjects (0.24) than in controls (0.42). Seventy-five per cent of glucose abstracted from blood, therefore, remains unaccounted for and theoretically available for complete oxidation. This yields a G -L/02 ratio (see footnote to Table II $ G-L/02 = 100 (glucose A-V difference -j lactate A-V difference)/, oxygen A-V difference. Since that fraction of glucose, unaccounted for by lactate production, is available for complete oxidation and since 6 moles of oxygen are required for complete oxidation of 1 mole of glucose, this ratio yields the fraction of oxygen accounted for if all the glucose abstracted from blood were completely oxidized. Mean value for G -L/02 is calculated from the mean glucose A-V difference, mean lactate A-V difference, and mean 02 A-V difference. Evidence for endogenous hyperinsulinism In control subjects, A-DV concentration differences reflect chiefly metabolism of muscle and A-SV, chiefly metabolism of skin and subcutaneous adipose tissue. A-SV glucose differences are greater (more positive) and A-SV 02 differences are smaller (less positive) than the respective A-DV differences. Lactate and FFA SV-A differences are greater (more negative), whereas potassium SV-A differences are smaller (less negative) than the respective DV-A differences (8) .
It is conceivable but unlikely that differences between control and obese subjects with respect to A-DV concentrations and values for Q represent nothing more than the increased contribution to DV effluent of blood draining the larger mass of adipose tissue in the obese forearm. If this effect were responsible for the increase in Q of glucose and absence of negative Q of potassium in obese subjects, then A-DV differences of all metabolites in obesity ought to show the same tendency to resemble A-SV differences of controls. Our studies do not, however, support this interpretation: A-DV 02, CO2, and lactate differences in obese subjects did not differ from A-DV concentrations of control subjects, but clearly differed from their A-SV concentrations (Tables I and   II) .
These findings also negate the possibility that our observations -merely represent redistribution of blood between deep and superficial forearm drainage beds. This would uniformly obscure or eliminate the differences normally found in A-V concentration differences of metabolites from the two drainage beds. A-DV 02, C0,, and FFA differences clearly differ from A-SV differences in obese subjects. (Compare Tables I and II  with Table III.) It is probable, therefore, that deviations from normal forearm metabolism in obese subjects cannot be attributed solely either to alterations in forearm blood flow or to the undoubtedly greater mass of adipose tissue in 'the obese forearm.
Previous studies from'this laboratory (7) have demonstrated that insulin infused into the brachial artery of control subjects reverses the net potassitum efflux and increases glucose uptake by forearm muscle. Only a minor fraction of the glucose is accounted for by lactate production and none is oxidized to CO.,. The RQ of forearm muscle does not rise. The effect of insulin on the superficial drainage bed of the forearm is to increase A-SV glucose concentration difference, with a fall in the L/G ratio, and to convert basal negative A-SV FFA differences to a net positive A-SV difference (11) . Metabolic events in the forearm of obese subjects in the absence of exogenous insulin resemble those in the normal forearm exposed to insulin and suggest that in obesity there is hyperinsulinism that is presumably adaptive to unusual quantities of substrate. This hypothesis was advanced by Brobeck, Tepperman, and Long (12) some years ago and gains support from the demonstration of islet cell hyperplasia in the' early or "active" phase of obesity by Ogilvie in man (13) and by Mayer (14) in rats.
We are very grateful to Drs. S. A. Berson -and R. S. Yalow for determining for us by their im-munoassay technique (15) plasma insulin concentrations in our six obese subjects and in four normal subjects of the same age group. Results appear in Table IV . Plasma insulin concentration was higher in obese subjects than in those of normal body weight (p < 0.01), although insulin concentration in our normal group may be slightly less than in the over-all experience of Yalow and Berson (15) .
Effect of insulin on forearm muscle metabolism
Results appear in Table V . Insulin concentration in forearm plasma. This is established by determining the ratio of the known rate of injection of insulin, 100 uU per kg per minute, to forearm plasma flow measured by Evans blue dye. Values varied from 200 to 450 ,uU per ml, levels comparable to those achieved in an earlier study on control subjects (7).
Plasmna flow. It has been pointed out repeatedly that both blood flow and arterial concentration must remain constant for proper employment of the Fick principle (16) . Plasma flow before and during the period of insulin infusion remained acceptably constant; that is, it did not vary by more than 20 per cent about the mean in any of the subjects studied. In one subject, P, a marked increase in plasma flow occurred in the period after the insulin infusion.
Arterial concentrationzs. Mean changes of less than 4 per cent were recorded in arterial glucose, lactate, and potassium concentrations during and after insulin administration. Arterial concentration of FFA tended to be more unstable than other (Figure 1 ). In only one of the six obese subjects did the A-DV concentration difference exceed 1 I.mole per ml, and the maximal uptake achieved was always less than 5 1imoles per minute per 100 ml forearm, which was the lowest peak effect recorded in any of the control subjects (7).
Lactate. There was a small but definite increase in lactate production during and after insulin administration. Since glucose uptake increased to a greater extent than lactate production, the L/G ratio dropped from a control value of 0.24 to less than 0.10.
Qo2, Qco2, and RQ. Observations on 02 consumption, CO2 production, and RQ were fragmentary only, being confined to the 26 minute sample, taken just before the conclusion of the insulin infusion, and the 60 minute sample. Such measurements as were made showed no change in either Qo2, QCo2, or RQ which corresponds with our experience in control subjects.
Potassium. In the basal state, the net movement of potassium out of forearm muscle into veous blood is absent in obese subjects. Administration of insulin resulted in mean potassium A-DV differences becoming more positive. Total movement of potassium achieved under the influence of exogenous insulin was significantly less in obese subjects than the comparable change in control subjects (Figure 2) . FFA. A-DV concentration difference of FFA increased from a mean basal value not significantly different from zero to 0.1 u.tEq per ml after insulin administration. This effect is probably achieved through inhibition of FFA release from adipose tissue interspersed between muscle fibers. Uptake of FFA by forearm muscle unmasked by insulin administration is sufficient to account for about 50 per cent of its 02 consumption.
Effect of insulin on forearm skin and subcutaneous adipose tissue metabolism
Values for A-SV concentration differences of glucose, lactate, and FFA after insulin administration, determined in five obese subjects, are shown in Table VI . In the sixth subject, L, the SV catheter was accidentally dislodged.
Glucose. Glucose A-SV differences increased after insulin administration, but significantly less so than in controls.
Lactate. There was a small but significant increase in lactate SV-A differences. The L/G ratio dropped fromr 0.31 to 0.22.
FFA. Insulin effectively inhibited release of FFA from forearm adipose tissue in obese subjects. Insulin-induced change in A-SV FFA concentration difference was significantly less in obese subjects than in controls (Figure 3 ). 1in or that they are in fact also resistant to their own insulin.
For the first solution, we have considered only the possibility that they might appear superficially to resist exogenous insulin if the quantity administered were superimposed on such a large pool that the relative increase in concentration is small compared to that after administration of the same amount to normal subjects. The obese subject, moving up the dose-response curve only slightly, would then display only a small metabolic response to insulin, appropriate to the normal doseresponse curve, and would not be truly insulinresistant. This hypothesis, however, is untenable in that the quantity of insulin administered to obese subjects was sufficient to raise forearm arterial insulin concentration by about 15 times, so that if they were not truly insulin-resistant, as we have defined the phrase, they ought to have responded quantitatively like normal subjects.
The second solution to the paradox is more likely, i.e., obese subjects may be resistant to their own insulin. We have no data on the insulin dose-response curve describing forearm metabolism, so we cannot say that normal subjects, in whom insulin concentration was as high as that found endogenously in obese subjects, would respond to a greater extent, but we suspect that this is the case. This suspicion is not weakened by the report by Karam, Grodsky, and Forsham (17) that in obesity an apparently normal response to glucose tolerance tests occurs only at the expense of an abnormally large increase in circulating insulin. This is reminiscent of the pattern described by Yalow and Berson (15) (18) . It is apparent that some of the features associated with this condition are shared by subjects with simple obesity, for example, elevation of plasma insulin concentration (15) , resistance to exogenous insulin with respect to glucose movement into forearm muscle (19) , and a greatly exaggerated plasma insulin response to a glucose load (17) . The following sequence is suggested: chronic substrate excess in obesity causes adaptive hyperinsulinism, leading ultimately to "high output failure" of the pancreatic islets. In line with this, Ogilvie (20) found that whereas glucose tolerance was usually normal in the early phases of obesity, it was abnormal in all subjects in whom obesity had been present for longer than 18 years. In John's series (21), evidence of glucose intolerance was present in over half the adult obese subjects he examined, but this was not the case in obese children. The factors that determine whether the obese subject adapts successfully or not to chronic substrate excess remain to be established. One important link is probably provided by the recent demonstration by Vallance-Owen and Lilley (22) of an antagonist to insulin in the plasma of obese prediabetics.
Possible factors producing insulin resistance in simple obesity
There remains the question of why insulin resistance occurs in obesity. Eckert, Green, and Mfigeon (23) found cortisol production increased in simple obesity. Although this suggests that insulin resistance in obesity may result from cortisol antagonism, it is unlikely that this is the case. In disturbances of the hypophyseal-adrenocortical axis, including Cushing's syndrome (24) , the metabolic pattern of insulin resistance differs from that in obesity. In obesity, there is resistance to all the metabolic effects of insulin we have studied, but in disease of the hypophyseal-adrenocortical axis, expressions of insulin resistance are limited to less responsiveness with respect to glucose and potassium uptake by the forearm tissues, and insulin-induced inhibition of FFA release from forearm adipose tissue is at least normal.
We are left with no really completely satisfying explanation of insulin resistance in obesity. It is possible that resistance in this case is simply a manifestation of tolerance to chronic (endogenous) administration of insulin.
Whatever the explanation, insulin resistance appears to be a consequence of obesity and not a primary defect. It was reversed after shedding of excess adipose tissue in one subject (unpublished observations by Andres, Baltzan, and Zierler), and Newburgh and Conn (24) found that, even in later stages of obesity, abnormal responses to glucose tolerance tests disappeared after weight loss.
1. Forearm metabolism (glucose and potassium uptake and lactate production by muscle, and release of free fatty acids from adipose tissue) in obese subjects not receiving insulin resembles that of normal subjects in whom insulin is infused intra-arterially. From this effect, confirmed by assay of plasma insulin concentration, it is likely that hyperinsulinism accompanies early obesity.
2. The respiratory quotient of forearm muscle in obese subjects is 0.7, as in normal muscle, which is compatible with oxidation of lipid.
3. Intra-arterial administration of insulin produces significantly less glucose and potassium uptake by forearm muscle and significantly less glucose uptake and movement of free fatty acids in forearm adipose tissue in obese subjects than in controls.
4. These studies may provide a link in the chain of evidence incriminating simple obesity as a precursor of maturity onset stable diabetes.
